Episode notes
Discussing the FDAs recent reversal on compounding Terzepitide while they re-evaluate the shortage situation. This and more on today's episode.
Keywords
shortagecompounded medicationsbranded medicationsTerzepitidemanufacturingFDAstop manufactureconsequencesreversal